Assignee
VIVAS MEJIA PABLO E
US·3 granted patents·1 pending application·3 citations·filing 2015–2020
Top patents by PatentIndex Score
4 records- 0178US9895312B2Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancerVIVAS MEJIA PABLO E·Filed 2015·Granted Feb 20, 2018·2 cites·2 claims
- 0276US10548842B2Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancerVIVAS MEJIA PABLO E·Filed 2018·Granted Feb 4, 2020·1 cites·22 claims
- 0361US11090266B2Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancerVIVAS MEJIA PABLO E·Filed 2020·Granted Aug 17, 2021·0 cites·11 claims
- 0435US2018193267A1Nanoliposomal formulation for targeting integrin-linked kinase (ilk) with small-interference rna and a method for treating ovarian cancerVIVAS MEJIA PABLO E·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →